Array‐comparative genomic hybridization of central chondrosarcoma
- 5 July 2006
- Vol. 107 (2) , 380-388
- https://doi.org/10.1002/cncr.22001
Abstract
BACKGROUND.: Enchondromas are benign lesions that can occur as solitary tumors or multiple tumors (Ollier disease) and may be precursors of central chondrosarcomas. Recurrent chondrosarcomas can be of a higher grade compared with primary tumors, suggesting possible progression.METHODS.: Genome‐wide array‐comparative genomic hybridization (CGH) was used to investigate copy number changes in enchondromas and central chondrosarcomas to elucidate both primary genetic events and the events related to tumor progression. Analyses of variance, Student t tests, and hierarchical clustering were used for the current analyses. Array‐CGH data were compared with complementary DNA (cDNA) and quantitative reverse‐transcriptase polymerase chain reaction expression array data.RESULTS.: Genomic imbalances were rare in enchondromas and in grade I chondrosarcomas, whereas they were frequent in high‐grade tumors. No genomic imbalances that were specific for Ollier disease were found. The authors identified 22 chromosome regions that were imbalanced in ≥25% of tumors, and 3 of those regions were located on chromosome 12 (12p13, 12p11.21‐p11.23, and 12q13, containing among others the PTPRF‐interacting protein‐binding protein 1 (PPFIBP1) gene. Loss of chromosome 6 and gain of 12q12 were associated with higher grade. Comparison of array‐CGH with cDNA expression showed correlations for the ribosomal protein S6 (RPS6) and cyclin‐dependent kinase 4 (CDK4) genes.CONCLUSIONS.: In the current study the authors identified genomic regions and new candidate genes (RPS6, CDK4, and PPFIBP1) that were associated with tumor progression and prognosis in patients with high‐grade chondrosarcomas. Cancer 2006. © 2006 American Cancer Society.Keywords
This publication has 27 references indexed in Scilit:
- Molecular analysis of the INK4A/INK4A‐ARF gene locus in conventional (central) chondrosarcomas and enchondromas: indication of an important gene for tumour progressionThe Journal of Pathology, 2004
- Updates on the cytogenetics and molecular genetics of bone and soft tissue tumors: chondrosarcoma and other cartilaginous neoplasmsCancer Genetics and Cytogenetics, 2003
- Diagnosis and prognosis of chondrosarcoma of boneExpert Review of Molecular Diagnostics, 2002
- A mutant PTH/PTHrP type I receptor in enchondromatosisNature Genetics, 2002
- Chromosome 9 Alterations and Trisomy 22 in Central Chondrosarcoma: A Cytogenetic and DNA Flow Cytometric Analysis of Chondrosarcoma SubtypesDiagnostic Molecular Pathology, 2001
- Malignant progression in multiple enchondromatosis (Ollier's disease): An autopsy-based molecular genetic studyHuman Pathology, 2000
- Loss of heterozygosity and DNA ploidy point to a diverging genetic mechanism in the origin of peripheral and central chondrosarcomaGenes, Chromosomes and Cancer, 1999
- EXT-Mutation Analysis and Loss of Heterozygosity in Sporadic and Hereditary Osteochondromas and Secondary ChondrosarcomasAmerican Journal of Human Genetics, 1999
- Homozygous deletion frequency and expression levels of the CDKN2 gene in human sarcomas - relationship to amplification and mRNA levels of CDK4 and CCND1British Journal of Cancer, 1995
- Prognostic factors in chondrosarcoma of bone.A clinicopathologic analysis with emphasis on histologic gradingCancer, 1977